CORY D LAMAR

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Epilepsy NAPLES, FL NPI 1740469030

General Payments — all program years on this page

$339.37

  • Category: General Payments
  • Program years: PY2018
  • Record count: 18
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $339.37 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $339.3718

By paying entity

Latest program year (PY2018) · sorted by reported total.

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $122.169
EISAI INC. $83.491
UCB, Inc. $53.623
MDD US Operations, LLC $27.482
Amgen Inc. $23.531
NOVARTIS PHARMACEUTICALS CORPORATION $15.051
Genentech USA, Inc. $14.041

By program year

Program yearAmountRecords
2018 $339.3718

Records — PY2018 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
546082027 UCB, Inc. $21.92 10/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
546106887 UCB, Inc. $16.84 03/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
546120179 UCB, Inc. $14.86 02/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567097553 Amgen Inc. $23.53 10/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602532789 Genentech USA, Inc. $14.04 11/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
603764461 Eisai Inc. $83.49 05/16/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608083949 US WorldMeds, LLC $13.77 08/28/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608084069 US WorldMeds, LLC $13.71 11/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608450529 Novartis Pharmaceuticals Corporation $15.05 12/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737789 Supernus Pharmaceuticals, Inc. $23.27 03/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737791 Supernus Pharmaceuticals, Inc. $21.06 05/30/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737793 Supernus Pharmaceuticals, Inc. $22.98 08/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737795 Supernus Pharmaceuticals, Inc. $7.11 10/03/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737797 Supernus Pharmaceuticals, Inc. $18.54 11/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737799 Supernus Pharmaceuticals, Inc. $9.60 11/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737801 Supernus Pharmaceuticals, Inc. $10.31 11/28/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737803 Supernus Pharmaceuticals, Inc. $1.82 12/05/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615737805 Supernus Pharmaceuticals, Inc. $7.47 12/12/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.